Presentation and diagnosis of allergic bronchopulmonary aspergillosis in asthma

Allergic bronchopulmonary aspergillosis (ABPA) can be difficult to detect and the diagnosis is often delayed because the presentation is nonspecific.

Consider the possibility of ABPA in a patient with:

  • unexplained shadowing on chest X-ray
  • segmental collapse on chest X-ray
  • difficult-to-control asthma (despite management of comorbidities such as allergic rhinitis)
  • a productive cough of sticky mucous plugs or blood
  • recurrent asthma exacerbations
  • haemoptysis.

ABPA should also be considered in a patient who appears to have pneumonia on X-ray but is reasonably well. Although a computed tomography (CT) scan is not a routine diagnostic test for ABPA, if it was performed because pneumonia was a presumed diagnosis and the scan shows mucous plugging, bronchiectasis, bronchial dilatation or airspace change, this may indicate ABPA.

If ABPA is suspected in a patient with asthma, or if a patient with asthma displays any of the above features without an alternative cause, consider referral to a respiratory physician for diagnosis and management. Features that are of particular concern are haemoptysis and transient pulmonary infiltrates on chest X-ray.

Diagnosis of ABPA requires specialist advice; it involves chest X-ray and serum-specific immunoglobulin E (IgE) tests (‘RAST’ tests). See International Society for Human and Animal Mycology (ISHAM) diagnostic criteria for allergic bronchopulmonary aspergillosis for diagnostic criteria.
Figure 1. International Society for Human and Animal Mycology (ISHAM) diagnostic criteria for allergic bronchopulmonary aspergillosis.

[NB1]

Obligatory criteria (both must be present):

  • positive type 1 Aspergillus skin test (immediate cutaneous hypersensitivity to Aspergillus antigen) or elevated IgE levels against Aspergillus fumigatus
  • elevated total IgE levels greater than 1000 IU/mL [NB2]

Additional criteria (at least two must be present):

  • presence of precipitating or IgG antibodies against A. fumigatus in serum
  • radiographic pulmonary opacities consistent with ABPA (eg transient pulmonary infiltrates)
  • total eosinophil count more than 500 cells/microlitre in steroid-naive patients
Note:

ABPA = allergic bronchopulmonary aspergillosis; IgE = immunoglobulin E; IgG = immunoglobulin G

NB1: Diagnosis is complex and usually requires specialist input.

NB2: If the patient meets all other criteria, an IgE value less than 1000 IU/mL may be acceptable.

Reproduced with permission from Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013;43(8):850-73. [URL]